Watch Now

View All
About Savonix
Savonix brings you the world’s first clinical, evidence-based, and all-mobile digital assessment of cognitive and emotional function. For micro-testing at frequent intervals, the test takes as little as three minutes. For a fully integrated neuropsychological battery of 12 domains, testing requires up to 30 minutes. Savonix works with any iOS or Android device and is available via license with healthcare organizations and other third-party partners.
State of Dementia
It is estimated that nearly 500,000 new cases of Alzheimer's disease will be diagnosed this year in the United States. Every 3 seconds, someone in the world develops dementia.
Dementia is about more than Memory
Memory impairment is not always the first symptom of dementia disorders. Studies show that up to 20 percent of people who later develop dementia show no signs of memory impairment in the early stages and that impairments in one domain alone are often benign.
In contrast, studies have also shown that multidomain assessment can pick up a range of cognitive problems at an early stage and up to 60 percent of people who later develop dementia present with multidomain impairments at the mild cognitive impairment (MCI) stage.

Press Releases

View All
Bayer Selects Savonix Digital Cognitive Assessment Platform to Validate the Effects of Multivitamin Supplement Berocca in Malaysia
September 17, 2019
Savonix Announces Publication in Cognition, Brain, Behavior
July 8, 2019
Savonix Announces Poster Presentation at the 2019 Alzheimer’s Association International Conference (AAIC)
July 2, 2019

In the News

View All
The Funded: New Bay Area IPO filings, $60M in funding deals
www.bizjournals.com
August 29, 2019
Savonix adds another $9.6M for cognitive assessment app
www.mobihealthnews.com
April 25, 2019
Women in IT Awards Asia 2019: shortlist revealed for inaugural awards
www.information-age.com
May 29, 2019

Past Events & Conferences

View All
BIO 2019
Brain Health Panel: Beyond Dementia: The REALLY Big Opportunities in Neuroscience
Jun 4, 2019— 11:00 AM – 12:15 PM ET
Philadelphia Convention Center, 116, Level 100
Global CEO Initiative on Alzheimer’s Disease (CEOi)
Presentation: Scaling Support through Technology
June 5, 2:00 – 5:00 PM
AARP Global Headquarters, 601 E Street, NW, Washington, DC
Global Insurtech Leaders Summit
Panel: What Insurance Innovation for Longevity and Aging Means?
June 19, 2019 — 12:35 – 1:15 PM
One Liberty Plaza, New York, NY